Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Reactions Weekly
Published in: Reactions Weekly 1/2017

01-09-2017 | Case report

Etanercept

Maculopapular rash and toxic epidermal necrosis: 2 case reports

Published in: Reactions Weekly | Issue 1/2017

Login to get access

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
…
Literature
Hohlfelder BA, et al. Etanercept for the Treatment of Transplantation-Related Lung Injury after Hematopoietic Stem Cell Transplantation. American Journal of Therapeutics 24: e386-e392, No. 4, Jan 2017 - USA
Metadata
Title
Etanercept
Maculopapular rash and toxic epidermal necrosis: 2 case reports
Publication date
01-09-2017
Publisher
Springer International Publishing
Published in
Reactions Weekly / Issue 1/2017
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-017-35650-6

Other articles of this Issue 1/2017

Reactions Weekly 1/2017 Go to the issue

Case report

Methylprednisolone/prednisolone/zoledronic-acid

Case report

Bosutinib

Case report

Oxycodone misuse

Case report

Nivolumab

Case report

Bexarotene

Case report

Perampanel